What is your recommendations for vaccines to prevent shingles in CLL patients?
1
1 Answers
Mednet Member
Medical Oncology · Mayo Clinic College of Medicine and Science (Scottsdale)
In October 2017, the U.S. FDA licensed the adjuvanted, recombinant zoster vaccine (Shingrix). Phase 1/2a studies in immunocompromised subjects, including autologous hematopoietic cell transplant recipients and HIV- infected adults, have confirmed that Shingrix is immunogenic and safe with no documen...